Israel Englander Assembly Biosciences, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $1.25 $2,102 - $4,042	3,234 Added 0.22%	1,450,049 $1.19 Million
Q2 2023 Aug 14, 2023	SELL	$0.81 - $1.15 $2,569 - $3,647	-3,172 Reduced 0.22%	1,446,815 $1.66 Million
Q1 2023 May 15, 2023	SELL	$0.8 - $1.74 $38,095 - $82,857	-47,619 Reduced 3.18%	1,449,987 $1.22 Million
Q4 2022 Feb 14, 2023	SELL	$1.09 - $20.4 $53,726 - $1.01 Million	-49,290 Reduced 3.19%	1,497,606 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$1.7 - $20.52 $218,817 - $2.64 Million	128,716 Added 9.08%	1,546,896 $2.54 Million
Q2 2022 Aug 15, 2022	BUY	$1.35 - $2.29 $71,761 - $121,729	53,157 Added 3.89%	1,418,180 $2.98 Million
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $1.51 Million - $2.53 Million	1,031,087 Added 308.77%	1,365,023 $2.81 Million
Q4 2021 Feb 14, 2022	BUY	$2.13 - $3.46 $103,322 - $167,837	48,508 Added 16.99%	333,936 $778,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $775,262 - $962,906	-246,899 Reduced 46.38%	285,428 $993,000
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $1.69 Million - $2.03 Million	445,090 Added 510.21%	532,327 $2.07 Million
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $377,736 - $578,381	87,237 New	87,237 $401,000
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $93,623 - $266,648	-11,199 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $1.97 Million - $2.97 Million	-200,510 Reduced 94.71%	11,199 $110,000
Q2 2019 Aug 15, 2019	BUY	$12.9 - $20.8 $2.61 Million - $4.22 Million	202,648 Added 2236.49%	211,709 $2.86 Million
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $287,450 - $463,486	-22,283 Reduced 71.09%	9,061 $690,000
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $554,788 - $781,405	31,344 New	31,344 $617,000
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $1 Million - $1.92 Million	-52,647 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $942,421 - $1.21 Million	27,388 Added 108.43%	52,647 $1.96 Million
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $248,473 - $318,687	-6,337 Reduced 20.06%	25,259 $990,000
Q1 2018 May 15, 2018	SELL	$41.7 - $64.16 $4.26 Million - $6.55 Million	-102,070 Reduced 76.36%	31,596 $1.55 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $891,553 - $1.56 Million	31,195 Added 30.44%	133,666 $6.05 Million
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $2.37 Million - $3.58 Million	102,471	102,471 $3.58 Million

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$240,646
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account